Industry Leaders Welcome New Study of Save Foods’ Treatment Showing Extended Shelf-Life of Mangos While Virtually Eliminating Post-Harvest Pesticides
June 21, 2022 08:30 ET | Save Foods Inc
Following the mango study results, Galilee Export, Israel’s second-largest fresh produce exporter, plans to use Save Foods’ solution for its mangos in the upcoming 2022-2023 season Miami, FL,...
Logo 1.png
Update on Positive Pre-Clinical Results from AIM Biologicals Development Program for the Potential Treatment of Parkinson’s Disease
May 12, 2022 08:05 ET | Aeterna Zentaris Inc
– Data presented at IMMUNOLOGY2022™, the Annual Event of the American Association of Immunologists – Company advancing development of its Autoimmunity Modifying (“AIM”) Biologicals as a potential...
CLINUVEL progresses vitiligo treatment program
May 09, 2022 21:33 ET | Clinuvel Pharmaceuticals Limited
MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder vitiligo will undergo further studies in North America this year. The drug afamelanotide...
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
May 03, 2022 09:30 ET | Curative Biotechnology, Inc. 
National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA) Boca Raton, FL, May 03, 2022 (GLOBE NEWSWIRE) -- Curative...
Axim-Sapphire_Logo_-04 (1).png
AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests
April 27, 2022 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting Dry Eye...
New Book by Psychiatrist and Mental Health Advocate Launches - The Promise of Psychedelics
April 22, 2022 11:31 ET | Ingenium Books (955172)
EDMONTON, Alberta, April 22, 2022 (GLOBE NEWSWIRE) -- Easy to read, yet backed by research, Dr. Peter Silverstone's new book, The Promise of Psychedelics: Science Based Hope for Better Mental...
New Book by Psychiatrist and Mental Health Advocate, The Promise of Psychedelics, Launches Today
April 21, 2022 10:00 ET | Ingenium Books
EDMONTON, Alberta, April 21, 2022 (GLOBE NEWSWIRE) -- Easy to read, yet backed by research, Dr. Peter Silverstone's new book, The Promise of Psychedelics: Science Based Hope for Better Mental...
Team SECU Puts Their Best Foot Forward for the Credit Union Cherry Blossom Run in the Nation’s Capital
April 08, 2022 13:42 ET | State Employees' Credit Union (SECU)
RALEIGH, N.C., April 08, 2022 (GLOBE NEWSWIRE) -- A group of avid runners and walkers from State Employees’ Credit Union (SECU) was in Washington, D.C. on April 3rd representing Team SECU in the...
IMAC Holdings, Inc. Announces Initiation of Third and Final Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
March 24, 2022 08:00 ET | IMAC Holdings, Inc.
BRENTWOOD, Tenn, March 24, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the third and final cohort of its Phase 1 clinical...
Hydroxyurea-based treatment for sickle cell anemia previously available for pediatric patients now approved for use in adults
February 16, 2022 07:00 ET | Medunik USA
ROSEMONT, PA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Medunik USA is pleased to announce that Siklos® (hydroxyurea), previously indicated to reduce the frequency of painful crises and to reduce the need...